Keyphrases
Anti-CTLA-4
14%
Antigen-presenting Cells
14%
Antigenic Stimulation
14%
Autoimmune Disease
14%
Carbodiimide
14%
CD28
28%
Cell Cycle Progression
14%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
100%
Ethylene
14%
Experimental Autoimmune Encephalomyelitis
14%
IL-2 Production
14%
Immunogenic
14%
Inflammatory Conditions
14%
Intravenous Administration
14%
Peripheral T Cells
100%
Peripheral Tolerance
14%
Production Cell
14%
Reverse Tolerance
14%
Signal Blockage
14%
Signaling Pathway
14%
Splenocytes
28%
T Cell Activation
28%
T Cell Differentiation
28%
T Cell Receptor
14%
T Cell Regulation
14%
T Cell Survival
14%
T Cells
14%
T-cell Tolerance
100%
Tolerance Induction
28%
Tolerogenic
14%
Immunology and Microbiology
Antigen-Presenting Cell
12%
Autoimmune Disease
12%
CD28
25%
Cell Cycle Progression
12%
Cell Differentiation
25%
Cell Survival
12%
CTLA-4
100%
Experimental Autoimmune Encephalomyelitis
12%
Immune Tolerance
12%
Interleukin 2
12%
Signal Transduction
12%
Splenocyte
25%
T Cell
25%
T Cell Activation
25%
T Cell Receptor
12%
T Cell Regulation
12%
T-Cell Tolerance
100%
Medicine and Dentistry
Antigen Presenting Cell
12%
Autoimmune Disease
12%
Cell Cycle Progression
12%
Cell Differentiation
12%
Cell Survival
12%
CTLA-4
100%
Cyanamide
12%
Ethylene
12%
Experimental Autoimmune Encephalomyelitis
12%
Immunological Tolerance
12%
Interleukin 2
12%
Reverse Tolerance
12%
Serositis
12%
Signal Transduction
12%
T Cell
12%
T Cell Activation
25%
T Cell Differentiation
12%
T Cell Regulation
12%
T Lymphocyte Receptor
12%
T-Cell Tolerance
100%